← Back to Clinical Trials
Recruiting NCT07522671

NCT07522671 Clinical Performance of 3D-Printed Resin and Zirconia Implant Restorations

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07522671
Status Recruiting
Phase
Sponsor Menoufia University
Condition Prosthesis User
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-04-01
Primary Completion 2027-04-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
3D-Printed Resin Restoration (CROWNTEC)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-04-01 with a primary completion date of 2027-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled clinical trial evaluates the clinical performance of 3D-printed resin restorations compared with milled monolithic zirconia in implant-supported single crowns and short-span fixed partial dentures (FPDs). A total of patients requiring one or two implant-supported restorations in the mandibular anterior region were randomly allocated to receive either 3D-printed permanent resin restorations (CROWNTEC) or conventionally milled zirconia prostheses. All restorations were fabricated using a standardized digital workflow and assessed over a 12-month follow-up period. The primary outcome was restoration survival rate, while secondary outcomes included technical complications, peri-implant biological parameters, marginal bone level changes, and patient-reported satisfaction. This study aims to provide clinical evidence regarding the viability of 3D-printed definitive resin materials as an alternative to zirconia in implant prosthodontics.

Eligibility Criteria

Inclusion Criteria: * Participants must meet all of the following: * Age ≥18 years. * Have one or two osseointegrated dental implants requiring prosthetic restoration. * Demonstrate stable peri-implant tissues with no signs of inflammation or implant mobility. * Maintain good oral hygiene and controlled periodontal status. * Require either: * A single implant-supported crown, or * A short-span (maximum 3-unit) implant-supported fixed partial denture (FPD) supported by two implants in the mandibular anterior region. Exclusion Criteria: * Participants are excluded if they have any of the following: * Severe parafunctional habits (e.g., bruxism). * Uncontrolled systemic diseases affecting bone metabolism or healing. * Peri-implantitis or compromised implant stability. * Requirement for cantilever prostheses or long-span restorations, or FPDs in areas other than the mandibular anterior region.

Contact & Investigator

Central Contact

Mohammed A. Elsawy, PhD

✉ mohamed.elsawy@dent.menofia.edu.eg

📞 00201061314522

Frequently Asked Questions

Who can join the NCT07522671 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Prosthesis User. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07522671 currently recruiting?

Yes, NCT07522671 is actively recruiting participants. Contact the research team at mohamed.elsawy@dent.menofia.edu.eg for enrollment information.

Where is the NCT07522671 trial being conducted?

This trial is being conducted at Shibīn al Kawm, Egypt.

Who is sponsoring the NCT07522671 clinical trial?

NCT07522671 is sponsored by Menoufia University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology